Treatments
Here at RegeneSpine, we know how much pain can affect your life and relationships.
-->
Here at RegeneSpine, we know how much pain can affect your life and relationships.
Would you like to explore a nonsteroidal, non-opioid option other than surgery? Consider the Discovery 6603 Study!
The first step will be to meet with a member of the study team at your local research center to review an Informed Consent Form. This form fully explains the purpose of the study, possible risks and benefits and what will be expected of you as a participant. No procedures will begin until you have had all your questions answered and have signed this form signifying your understanding of its contents and your agreement to take part. Participants in this clinical research study will receive a single injection of the study drug (or a control injection). Involvement in the study will be about 12 months, during which participants will be asked to attend up to 11 study visits. You may be compensated for your time and travel. Throughout the study, staff will monitor your health. They will collect blood and urine samples for laboratory testing. Participants will also receive an MRI and X-Ray. You will be asked questions about leg and back pain, medications being taken, and any side effects that you might have experienced. You will be provided with an electronic device on which you can record your pain condition and medication use on a daily basis. Participants will not be allowed to use opioids or cannabis during the study; other pain medications may be available if needed.
Your lower back is made up of five lumbar vertebrae (bones) which surround and protect your spinal cord. Nerves travel along your spinal cord, sending information back and forth from your brain to other parts of your body. In between the vertebrae are flat, flexible discs that act as shock absorbers when you walk, run or jump. These discs have a flexible outer ring and a soft gel-like center.
You may be eligible to participate if you:
About 320 people in the United States will take part in this clinical research study. The active study drug is administered as a single injection and is being compared with a control injection (an injection that contains no medication). One out of two participants will receive the active study drug.